Iloprost for Bridging to Heart Transplantation in Patients with Pulmonary Hypertension and Left Heart Failure

Trial Profile

Iloprost for Bridging to Heart Transplantation in Patients with Pulmonary Hypertension and Left Heart Failure

Withdrawn prior to enrolment
Phase of Trial: Phase II

Latest Information Update: 14 Jul 2015

At a glance

  • Drugs Iloprost (Primary)
  • Indications Pulmonary hypertension
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms BRIDGE
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 25 Jun 2015 Status changed from recruiting to withdrawn prior to enrolment, as reported by ClinicalTrials.gov record.
    • 11 Jul 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top